Terremoto Biosciences Launches With $75 Million Series A Financing And Mission To Discover And Develop Groundbreaking Covalent Medicines
Amount Raised
$75 Million
Round Type
Series A
San FranciscoInformation TechnologyBiotechnologyScience And EngineeringDescription
Terremoto Biosciences, a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines, today announced it has raised $75 million in a Series A financing. The round was co-led by OrbiMed and Third Rock Ventures. Proceeds from the financing will be used to advance Terremoto’s lysine-targeted covalency platform and develop best-in-class therapies against known drug targets, as well as first-in-class medicines against the previously undruggable.
Quick answer
Terremoto Biosciences raised $75 Million in a Series A round, dated May 25, 2022. Terremoto Biosciences is based in San Francisco, California, United States.
- How much did Terremoto Biosciences raise?
- Terremoto Biosciences raised $75 Million in a Series A round on May 25, 2022.
- What does Terremoto Biosciences do?
- Terremoto Biosciences is a covalent drug discovery and development engine creating highly targeted, small molecule medicines with unmatched selectivity, potency and efficacy.
- Where is Terremoto Biosciences based and how big is it?
- Terremoto Biosciences is based in San Francisco, California, United States. Fundz records about 56 employees.
- Who are the decision-makers at Terremoto Biosciences?
- Fundz holds 4 contacts at Terremoto Biosciences, including the President and Head of Research and Development. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Terremoto Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Advanced NanoTherapies raised $7.2M (Series A) on June 28, 2022.
- PineTree Therapeutics raised $24M (Series A) on June 7, 2022.
- Upstream Bio raised $200M (Series A) on June 2, 2022.
- Transine® Therapeutics raised an undisclosed amount (Seed) on May 31, 2022.
- SentinelOne, Inc. raised $8M (Funding Round) on May 30, 2022.
- Full Life Technologies raised $37M (Series A) on May 26, 2022.
Who to call at Terremoto Biosciences, and when
A new round usually means Terremoto Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Terremoto Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Terremoto Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Terremoto Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Terremoto Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTerremoto Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.